Cargando…
Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153539/ https://www.ncbi.nlm.nih.gov/pubmed/36519329 http://dx.doi.org/10.3324/haematol.2022.281896 |
| _version_ | 1785035949114130432 |
|---|---|
| author | Knörr, Fabian Schellekens, Kim PJ Schoot, Reineke A Landman-Parker, Judith Teltschik, Heiko-Manuel Förster, Jan Riquelme, Amambay Huitema, Alwin DR van Eijkelenburg, Natasha KA Beishuizen, Auke Zwaan, C Michel Woessmann, Wilhelm van der Lugt, Jasper |
| author_facet | Knörr, Fabian Schellekens, Kim PJ Schoot, Reineke A Landman-Parker, Judith Teltschik, Heiko-Manuel Förster, Jan Riquelme, Amambay Huitema, Alwin DR van Eijkelenburg, Natasha KA Beishuizen, Auke Zwaan, C Michel Woessmann, Wilhelm van der Lugt, Jasper |
| author_sort | Knörr, Fabian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10153539 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101535392023-05-03 Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma Knörr, Fabian Schellekens, Kim PJ Schoot, Reineke A Landman-Parker, Judith Teltschik, Heiko-Manuel Förster, Jan Riquelme, Amambay Huitema, Alwin DR van Eijkelenburg, Natasha KA Beishuizen, Auke Zwaan, C Michel Woessmann, Wilhelm van der Lugt, Jasper Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-12-15 /pmc/articles/PMC10153539/ /pubmed/36519329 http://dx.doi.org/10.3324/haematol.2022.281896 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Knörr, Fabian Schellekens, Kim PJ Schoot, Reineke A Landman-Parker, Judith Teltschik, Heiko-Manuel Förster, Jan Riquelme, Amambay Huitema, Alwin DR van Eijkelenburg, Natasha KA Beishuizen, Auke Zwaan, C Michel Woessmann, Wilhelm van der Lugt, Jasper Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma |
| title | Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma |
| title_full | Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma |
| title_fullStr | Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma |
| title_full_unstemmed | Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma |
| title_short | Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma |
| title_sort | combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric alk-positive anaplastic large cell lymphoma |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153539/ https://www.ncbi.nlm.nih.gov/pubmed/36519329 http://dx.doi.org/10.3324/haematol.2022.281896 |
| work_keys_str_mv | AT knorrfabian combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT schellekenskimpj combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT schootreinekea combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT landmanparkerjudith combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT teltschikheikomanuel combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT forsterjan combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT riquelmeamambay combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT huitemaalwindr combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT vaneijkelenburgnatashaka combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT beishuizenauke combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT zwaancmichel combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT woessmannwilhelm combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma AT vanderlugtjasper combinationtherapywithcrizotinibandvinblastineforrelapsedorrefractorypediatricalkpositiveanaplasticlargecelllymphoma |